Dashboard
1
Poor Management Efficiency with a low ROCE of 4.39%
- The company has been able to generate a Return on Capital Employed (avg) of 4.39% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -3.40% and Operating profit at 22.02% over the last 5 years
3
With ROE of 6.95%, it has a very attractive valuation with a 2.61 Price to Book Value
4
Consistent Returns over the last 3 years
Stock DNA
Commercial Services & Supplies
CNY 23,174 Million (Large Cap)
38.00
NA
2.45%
-0.51
7.56%
2.29
Revenue and Profits:
Net Sales:
1,141 Million
(Quarterly Results - Sep 2025)
Net Profit:
241 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
58.11%
0%
58.11%
6 Months
58.39%
0%
58.39%
1 Year
37.39%
0%
37.39%
2 Years
111.19%
0%
111.19%
3 Years
193.93%
0%
193.93%
4 Years
209.14%
0%
209.14%
5 Years
195.87%
0%
195.87%
Wangsu Science & Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.40%
EBIT Growth (5y)
22.02%
EBIT to Interest (avg)
22.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.47
Tax Ratio
8.04%
Dividend Payout Ratio
90.58%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
4.39%
ROE (avg)
3.54%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
2.61
EV to EBIT
39.27
EV to EBITDA
26.30
EV to Capital Employed
7.30
EV to Sales
3.67
PEG Ratio
2.84
Dividend Yield
2.23%
ROCE (Latest)
18.58%
ROE (Latest)
6.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Jun 2017
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
1,141.30
1,115.60
2.30%
Operating Profit (PBDIT) excl Other Income
96.10
153.30
-37.31%
Interest
2.60
5.70
-54.39%
Exceptional Items
38.80
36.50
6.30%
Consolidate Net Profit
241.50
179.20
34.77%
Operating Profit Margin (Excl OI)
84.20%
93.30%
-0.91%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.30% vs -9.67% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 34.77% vs -5.88% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
4,925.40
4,700.50
4.78%
Operating Profit (PBDIT) excl Other Income
649.60
727.60
-10.72%
Interest
19.30
9.10
112.09%
Exceptional Items
30.80
-47.80
164.44%
Consolidate Net Profit
671.20
606.40
10.69%
Operating Profit Margin (Excl OI)
77.20%
79.60%
-0.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 4.78% vs -7.47% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 10.69% vs 229.39% in Dec 2023
About Wangsu Science & Technology Co., Ltd. 
Wangsu Science & Technology Co., Ltd.
Commercial Services & Supplies
No Details Available.
Company Coordinates 
No Company Details Available






